Tretoquinol

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C19H23NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JIO3275WGI, chemically known as 6,7-isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, hydrochloride, (s)- but generally known as tretoquinol, which bears US NIH Compound Identifier 29137. European Medicines Agency schedules Tretoquinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11248MIG. The term TRETOQUINOL is an International Non-Proprietary Name. World Health Organization schedules tretoquinol in its Anatomical Therapeutic Chemical (ATC) Classification. TRETOQUINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tretoquinol under HS 29334990 and SITC 51575. As of Q4 2014, TRETOQUINOL remains the US FDA Preferred Term for this commodity. Tretoquinol bears US NLM identifiers UMLS ID C0040846 and NCI Concept Code C66629. SMILES: CL.OC1CC2C(NCCC2CC1O)CC1CC(OC)C(OC)C(OC)C1.